In B-ALL, FLT3 mutations are less common, reported in 0.2%–12.5% of cases when evaluated by conventional techniques (RFLP and fragment analysis) (31–36) and in up to 25% when investigated using NGS (20). Here, FLT3 is linked to acute lymphoblastic leukemia.